Public Accounts committee  Mr. Chair, we actually reached out to multiple countries and offered those surplus vaccines. There were situations where, in addition to Latin America and Caribbean countries, there were African countries that also opted for that. We were diligent enough to send them not only the

Public Accounts committee  Mr. Chair, I'll add, just in terms of our own management of the supply, that we are very committed to doing work with PTs on the forward supply planning, informed by science and expert advice. We are also looking, as our colleagues from PSPC said, to adjust the delivery schedule

Public Accounts committee  Mr. Chair, I'll start and then pass to Luc.

Public Accounts committee  One of the things to start is that Deloitte was contracted specifically for VaccineConnect and not in general for the health data component, which was a part of our strategy in the pan-Canadian health data strategy. Luc, if you can elaborate a little on that....

Public Accounts committee  We have actually achieved close to 200 million doses. This is in terms of what we offered, which my notes say is around 196 million.

Public Accounts committee  Mr. Chair, we constantly work with the international donation organism, COVAX. We also have a good line of sight internationally in terms of the donations. The donation market is saturated, Mr. Chair, given that there are many countries that are trying to donate and also that the

Public Accounts committee  Mr. Chair, the donation aspect is based on the availability of the doses each country puts forward. Canada mentioned very early that we would be donating 200 million doses to COVAX. There are other countries that have greater access. For example, the U.S. went out and said they

Public Accounts committee  Mr. Chair, when we signed the seven APAs, that was the component where we actually locked in most of the vaccine manufacturers who could really produce a safe and effective vaccine.

Public Accounts committee  Mr. Chair, I'll attempt to clarify that wastage is inevitable in any immunization program. When we initially started the vaccination campaign, the unavoidable wastage was around 3%. Basically, when you open the vial, you have to use it within a 24-hour time period, or it cannot b

Public Accounts committee  I'll pass—

Public Accounts committee  Mr. Chair, this is something that is in active conversation between the company and ISED, who are the key interlocutors between the Government of Canada and the industry. That conversation is going on as such in terms of those details.

Public Accounts committee  As Dr. Lucas said, we have done a study in which we did modelling. According to that, almost 800,000 lives were saved, 1.9 million hospitalizations avoided and 34 million COVID cases prevented by making sure there was early access to vaccines and we had public health measures in

Public Accounts committee  Mr. Chair, I'll start by mentioning that we have been very diligent in working with COVAX, an international way of making sure that donations are equitably distributed. We have been able to donate. We offered almost 41.5 million doses as the doses became available. We also did it

Public Accounts committee  Can I pass it to you...? [Inaudible—Editor] numbers are probably different.

Public Accounts committee  Thank you, Mr. Chair. I will pass it on to Luc, but I will just mention that VaccineConnect was launched in 2021. It is an agile modular digital platform that was developed to address these urgent data needs. Luc, if I could, I'll pass it on to you, please.